Türk Uğur Önsel

Türk Uğur Önsel

Profile URL

https://hdl.handle.net/20.500.14365/7489

Name Variants

Önsel Türk, Uǧur
Turk, U. O.
Türk, Ugur Önsel
Turk, Ugur Onsel
Türk, Ug̈ur

Main Affiliation

09. Faculty of Medicine

Status

Former Staff

ORCID ID

https://orcid.org/0000-0001-6348-6616 View this author’s ORCID profile

Scopus Author ID

12774004400

Full item page

Sustainable Development Goals

Documents

72

Citations

850

h-index

16

Go to Scopus profile

This researcher does not have a WoS ID.

Scholarly Output

11

Articles

3

Views / Downloads

0/0

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

1

Scopus Citation Count

4

WoS h-index

1

Scopus h-index

1

Patents

0

Projects

0

WoS Citations per Publication

0.09

Scopus Citations per Publication

0.36

Open Access Source

3

Supervised Theses

0

Journal	Count

Page Size:

Current Page: 1 / NaN

Scopus Quartile Distribution

Competency Cloud

Scholarly Output Search Results

Now showing 1 - 10 of 11

Demographic, Clinical, and Disease Characteristics of Patients With Atrial Fibrillation on Edoxaban Therapy: What Are the Impacts of Heart Failure? a Subgroup Analysis From Etaf-Tr Study
(Kare Publ, 2022) Bakhshaliyev, Nijad; Coner, Ali; Altin, Cihan; Balli, Mehmet; Tasbulak, Omer; Totan, Sahin; Turk, Ugur Onsel
[Abstract Not Available]
Citation - WoS: 1
Citation - Scopus: 2
Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey Study: Design and Rationale
(Aves, 2022) Türk Uğur Önsel; Alioglu, Emin; Mavioglu, Zafer; Diker, Erdem; Ozpelit, Ebru; De Caterina, Raffaele
Objective: Safety and effectiveness of edoxaban was demonstrated in phase III, Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE-AF-TIMI 48) trial and is being confirmed in the post-authorization Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study in patients with atrial fibrillation. However. any post-authorization safety study focusing on the safety of edoxaban treatment in Turkey with a prospective design has not been performed yet. The Evaluation of Treatment Safety in Patients with Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (ETAF-TR) study is designed to evaluate the safety and effectiveness of edoxaban treatment in atrial fibrillation in routine practice. The present article describes the design and rationale for the ETAF-TR Study. Methods: The ETAF-TR (NCT04594915) is a national. multicenter. prospective, observational study that enrolled 858 patients from 32 centers. The primary outcome of the ETAF-TR study is any overt bleeding (consisting of major bleeding or clinically relevant nonmajor bleeding or any bleeding that does not meet this definition but is considered as overt bleeding by the participating physician). Effectiveness, treatment persistence. and posology will also be evaluated in an explorative manner. The overall duration of follow-up will be 1 year: the first patient was enrolled in August 2020. Conclusions: Results of ETAF-TR wilt add data from clinical practice to those from ENGAGE-AF trial and also ETNA-AF study. Comparing their results will enable to test the external validity of ENGAGE-AF trial in the country conditions.
Arrhythmia/Electrophysiology/Pacemaker/CRT-ICD
(Kare Publ, 2022) Boyuk, Ferit; Caliskan, Serhat; Kocabas, Umut; Cakmak, Ender Ozgun; Ozpelit, Ebru; Kasap, Mithat; Türk, Uğur Önsel
[Abstract Not Available]
Characteristics of Patients With Atrial Fibrillation on Edoxaban Treatment in Turkey: Baseline Data From Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (etaf-Tr) Study
(Kare Publ, 2022) Turk, Ugur Onsel; Uguz, Berat; Inci, Sinan; Dost, Sahin; Tuluce, Kamil; Totan, Sahin; Erturk, Emre
[Abstract Not Available]
New Oral AntiCoagulants Use in Renal Disease and AF (NOACURE-AF) Where do We Stand?: An Expert Consensus View Using the Delphi Method
(2021) Turk, Ugur Onsel; Alioglu, Emin; Ecder, Tevfik; Erdinler, Izzet Celal; Ok, Ercan; Ozluk, Ozlem Arican; Arıcı, Mustafa
-
Characteristics of Patients With Atrial Fibrillation on Edoxaban Treatment in Turkey: Does Health Provider Type Matter? a Report From Etaf-Tr Study
(Kare Publ, 2022) Kocabas, Umut; Demirci, Gokhan; Yagmur, Burcu; Saricam, Ersin; Mammadli, Anar; Kasap, Mithat; Turk, Ugur Onsel
[Abstract Not Available]
How Did the Population Characteristics of Engage-Af Trial Transcribed Real Life Conditions in Turkey: an External Validation Test With Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey (etna)
(Kare Publ, 2022) Baris, Veysel Ozgur; Erturk, Emre; Cetin, Nurullah; Bakir, Eren Ozan; Elcik, Deniz; Totan, Sahin; Turk, Ugur Onsel
[Abstract Not Available]
New Oral Anticoagulant Use in Renal Disease and Af (noacure-Af) Where Do We Stand? an Expert Consensus View Using the Delphi Method Reply
(Aves, 2021) Turk, Ugur Onsel; Arici, Mustafa
[Abstract Not Available]
Citation - Scopus: 1
New Oral Anticoagulants Use in Renal Disease and Af (noacure-Af) - Where Do We Stand?: an Expert Consensus View Using the Delphi Method
(Turkish Society of Cardiology, 2021) Arici M.; Ecder T.; Erdinler I.; Ok E.; Özlük Ö.A.; Türk U.Ö.; Alio?lu E.
[No abstract available]
Citation - Scopus: 1
A Statistical Perspective To the Qtc Interval in the Treatment of Covid-19
(Churchill Livingstone Inc Medical Publishers, 2021) Mert, Kadir Ugur; Turk, Ugur Onsel; Gorenek, Bulent
[Abstract Not Available]

Türk Uğur Önsel

Profile URL

Name Variants

Job Title

Email Address

Main Affiliation

Status

Website

ORCID ID

Scopus Author ID

Turkish CoHE Profile ID

Google Scholar ID

WoS Researcher ID

Sustainable Development Goals

Documents

72

Citations

850

h-index

16

This researcher does not have a WoS ID.

Scholarly Output

11

Articles

3

Views / Downloads

0/0

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

1

Scopus Citation Count

4

WoS h-index

1

Scopus h-index

1

Patents

0

Projects

0

WoS Citations per Publication

0.09

Scopus Citations per Publication

0.36

Open Access Source

3

Supervised Theses

0

Scopus Quartile Distribution

Competency Cloud

Filters

Settings

Sort By

Results per page

Scholarly Output Search Results